# Metabolic Effects of GH and IGF-I in Growth Hormone Deficient(GHD) and Diabetes and Impaired Glucose Tolerance(IGT)

> **NCT01020955** · PHASE3 · COMPLETED · sponsor: **Karolinska University Hospital** · enrollment: 14 (actual)

## Conditions studied

- Diabetes

## Interventions

- **DRUG:** NutropinAq (GH) and Increlex (IGF-I)
- **DRUG:** NutropinAq and placebo

## Key facts

- **NCT ID:** NCT01020955
- **Lead sponsor:** Karolinska University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2015-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01020955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01020955, "Metabolic Effects of GH and IGF-I in Growth Hormone Deficient(GHD) and Diabetes and Impaired Glucose Tolerance(IGT)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01020955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*